HE homepage

Trending
Private equity-backed cardiology practice adding new in-house smart lab powered by AI
Lawsuit dropped against squatter patient who refused to leave hospital room for 5 months
UnitedHealthcare launches generative AI ‘companion’ for patient care coordination
Report: GOP looking to cut healthcare to offset $200B Iran war spending
Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors
Thumbnail
Cardiologist was fired for speaking out about racist texts, private jet misuse, lawsuit claims

An interventional cardiologist believes he was targeted and terminated for being outspoken about a series of incidents at his hospital. 

broken relationship broken contract
Hospital sues cardiology practice for alleged breach of contract, ending years-long partnership

The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.  

legal liability malpractice artificial intelligence
Lawsuit against Elevance Health alleging use of ‘ghost networks’ officially moving forward

On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.

Alzheimer's
VA first to cover new ALZ drug

A new Alzheimer’s disease drug, Leqembi (lecanemab), will be covered by the Veterans Affairs for some patients, making the VA the first insurer to cover the drug.

To juice medical AI adoption, try a little Aristotelian persuasion

Wary consumers can be convinced to allow AI into their healthcare habits by communications campaigns tuned to the ancient rhetorical categories of ethos, pathos and logos. 

Pfizer
Pfizer to acquire Seagen for $43B

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Former CEO indicted for fake medical device implanted in patients

Laura Perryman, the former chief of Florida-based Stimwave, allegedly created a non-functioning “dummy device” that was used to treat patients suffering from chronic pain.

eye vision
FDA announces recall of two more eye drop brands

Use of the contaminated eye drops could result in eye infections that could lead to blindness, the FDA said.

Society for Cardiovascular Angiography and Interventions (SCAI) is asking its interventional cardiologist members to take action to prevent further cuts in Medicare payments in 2024 by contacting their Congressmen. There were substantial cuts in Centers for Medicare and Medicaid Services (CMS) payments to physicians in 2023 further cuts each year can only be prevented if Congress changes the laws for how CMS pays physicians.
Oversight Committee launches investigation into pharmacy benefit managers

CVS Caremark, Express Scripts and OptumRx have been asked to provide documents, communications and information related to their practices.

Around the web

Cardiovascular Business
FDA approves another GLP-1 pill for weight loss

The approval, made as part of a special FDA pilot program, took just 50 days.